GGrantIndex
← Search

PHASE I TRIAL TESTING MART-1 PEPTIDE IMMUNIZATION IN MALIGNANT MELANOMA

$207,266M01FY2001RRNIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →